Utilization of Stereotactic Ablative Radiotherapy in Oligometastatic & Oligoprogressive Skeletal Metastases: Results and Pattern of Failure

Asia-Pacific Journal of Clinical Oncology- United Kingdom

doi 10.1111/ajco.13115

Full Text

Abstract

Available in

Categories

Date

March 1, 2019

Authors

Oscar Siu Hong Chan

Albert Wai Man Hung

Rebecca Mei Wan Yeung

Publisher

Wiley

Related search

Utilization of Stereotactic Ablative Radiotherapy in the Management of Oligometastatic Disease

Current Oncology

English

Stereotactic Body Radiotherapy (SBRT) for Adrenal Metastases of Oligometastatic or Oligoprogressive Tumor Patients

Radiation Oncology

Nuclear Medicine

English

P3.01-69 Stereotactic Ablative Radiotherapy Improves Progression-Free Survival and Local Control in Oligometastatic Lung Cancer Patients

Journal of Thoracic Oncology

Respiratory Medicine

English

Stereotactic Ablative Radiotherapy Prolongs Surveillance and Delays Initiation of Systemic Therapy in Patients With Renal Cancer Metastases

International Journal of Radiation Oncology Biology Physics

Cancer Research

Nuclear Medicine

English

Stereotactic Ablative Radiation Therapy for the Treatment of Oligometastatic Prostate Cancer

International Journal of Radiation Oncology Biology Physics

Cancer Research

Nuclear Medicine

English

MS20.02 the Future of Stereotactic Ablative Radiotherapy (SABR)

Journal of Thoracic Oncology

Respiratory Medicine

English

Are We Ready for Histology-Driven Stereotactic Ablative Radiotherapy?

Journal of Thoracic Oncology

Respiratory Medicine

English

Stereotactic Radiotherapy in Epithelial Ovarian Cancer Brain Metastases Patients

Journal of Ovarian Research

English

Primary Lung Sarcoma Treated With Stereotactic Ablative Radiotherapy: A Case Report

OncoTargets and Therapy

English